Published in J Natl Cancer Inst on June 07, 2006
Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med (2014) 7.39
Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst (2009) 6.07
Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 4.83
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer (2010) 3.27
Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol (2014) 3.04
Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology (2008) 2.37
Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst (2011) 2.31
Quantification of harms in cancer screening trials: literature review. BMJ (2013) 1.77
Lung cancer screening. Br J Cancer (2010) 1.57
Volunteer effect and compromised randomization in the Mayo Project of screening for lung cancer. Eur J Epidemiol (2010) 1.42
Computed tomography screening for lung cancer. BMJ (2007) 1.30
Improving the biomarker pipeline to develop and evaluate cancer screening tests. J Natl Cancer Inst (2009) 1.24
Lung cancer screening, overdiagnosis bias, and reevaluation of the Mayo Lung Project. J Natl Cancer Inst (2006) 1.24
Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2012) 1.22
CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort. PLoS One (2012) 1.12
Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography. Br J Cancer (2008) 1.05
Squamous dysplasia--the precursor lesion for esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2013) 1.04
Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials. J Thorac Oncol (2010) 1.03
"Risk homeostasis"or "teachable moment"? the interaction between smoking behavior and lung cancer screening in the Mayo Lung Project. Tob Induc Dis (2011) 0.92
Lung cancer screening guidelines: common ground and differences. Transl Lung Cancer Res (2014) 0.90
Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations. EBioMedicine (2015) 0.83
Lung Cancer Screening With Low-Dose CT: Its Effect on Smoking Behavior. J Adv Pract Oncol (2013) 0.82
Cost of a 5-year lung cancer survivor. Br J Cancer (2009) 0.81
Healthcare use after screening for lung cancer. Cancer (2010) 0.80
Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study. Ann Surg Oncol (2015) 0.80
Comparing the benefits of screening for breast cancer and lung cancer using a novel natural history model. Cancer Causes Control (2011) 0.80
Modeling excess lung cancer risk among screened arm participants in the Mayo Lung Project. Cancer (2010) 0.78
Update on biomarkers for the detection of lung cancer. Lung Cancer (Auckl) (2012) 0.77
Long-term outcomes of a pilot CT screening for lung cancer. Ecancermedicalscience (2010) 0.77
Screening for lung cancer with low-dose computed tomography. Oncologist (2013) 0.75
Reconsidering lung cancer screening: is biannual screening possible? J Thorac Dis (2016) 0.75
Bilateral Adrenal Incidentalomas: A Rare Presentation of Lung Cancer. Case Rep Endocrinol (2015) 0.75
Re: Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst (2007) 0.75
Exploring the uncertainties of early detection results: model-based interpretation of mayo lung project. BMC Cancer (2011) 0.75
The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. Int J Cancer (2017) 0.75
Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med (2004) 11.52
Measured and estimated GFR in healthy potential kidney donors. Am J Kidney Dis (2004) 3.11
Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology (2007) 2.36
The phenotypic consequences of CFTR mutations. Ann Hum Genet (2003) 2.09
Predictors of 6-month tobacco abstinence among 1224 cigarette smokers treated for nicotine dependence. Addict Behav (2003) 2.07
Colorectal cancer screening with CT colonography, colonoscopy, and double-contrast barium enema examination: prospective assessment of patient perceptions and preferences. Radiology (2003) 2.04
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int (2005) 2.00
Randomized clinical trial of an Internet-based versus brief office intervention for adolescent smoking cessation. Patient Educ Couns (2006) 1.65
The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol (2003) 1.64
Increased risk associated with pulmonary artery catheterization in the medical intensive care unit. J Crit Care (2003) 1.63
The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol (2002) 1.60
Assessing the unmet information, support and care delivery needs of men with prostate cancer. Patient Educ Couns (2003) 1.57
Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant (2002) 1.52
Mortality in Parkinson's disease. Mov Disord (2010) 1.51
International registry for primary hyperoxaluria. Am J Nephrol (2005) 1.49
Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet (2003) 1.47
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression. Mod Pathol (2002) 1.43
Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol (2007) 1.39
Temporal regulation of CFTR expression during ovine lung development: implications for CF gene therapy. Hum Mol Genet (2002) 1.32
The impact of surgical approach (nerve bundle preservation versus wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy. J Urol (2004) 1.32
Intronic enhancers coordinate epithelial-specific looping of the active CFTR locus. Proc Natl Acad Sci U S A (2009) 1.29
Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy. J Urol (2004) 1.29
Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. J Urol (2002) 1.29
HNF1alpha is involved in tissue-specific regulation of CFTR gene expression. Biochem J (2004) 1.25
A complex intronic enhancer regulates expression of the CFTR gene by direct interaction with the promoter. J Cell Mol Med (2009) 1.23
Is smoking related to body image satisfaction, stress, and self-esteem in young adults? Am J Health Behav (2006) 1.21
An insulator element 3' to the CFTR gene binds CTCF and reveals an active chromatin hub in primary cells. Nucleic Acids Res (2009) 1.19
Tobacco and other substance use among Alaska Native youth in western Alaska. Am J Health Behav (2007) 1.17
Iqmik--a form of smokeless tobacco used by pregnant Alaska natives: nicotine exposure in their neonates. J Matern Fetal Neonatal Med (2005) 1.16
CTCF mediates insulator function at the CFTR locus. Biochem J (2007) 1.16
Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer. Genes Chromosomes Cancer (2002) 1.15
Focus groups of Y-K Delta Alaska Natives: attitudes toward tobacco use and tobacco dependence interventions. Prev Med (2004) 1.15
MicroRNA regulation of expression of the cystic fibrosis transmembrane conductance regulator gene. Biochem J (2011) 1.15
Evaluation of potential regulatory elements identified as DNase I hypersensitive sites in the CFTR gene. Eur J Biochem (2002) 1.14
Prostatitis as a risk factor for prostate cancer. Epidemiology (2004) 1.14
Training support persons to help smokers quit: a pilot study. Am J Prev Med (2004) 1.11
Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J Urol (2002) 1.10
Correlation of quantitative digital image analysis with the glomerular filtration rate in chronic allograft nephropathy. Am J Transplant (2004) 1.10
Increased faculty presence on inpatient teaching services. Mayo Clin Proc (2004) 1.08
The CFTR gene and regulation of its expression. Pediatr Pulmonol (2005) 1.07
Weight concerns among male smokers. Addict Behav (2004) 1.04
Provider satisfaction in clinical encounters with ethnic immigrant patients. Mayo Clin Proc (2003) 1.04
The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol (2005) 1.04
Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Cancer (2002) 1.02
Alternative 5' exons of the CFTR gene show developmental regulation. Hum Mol Genet (2003) 1.00
Telephone quitlines to help surgical patients quit smoking patient and provider attitudes. Am J Prev Med (2008) 1.00
Transcriptional networks driving enhancer function in the CFTR gene. Biochem J (2012) 1.00
Tobacco use and cessation among pregnant Alaska Natives from Western Alaska enrolled in the WIC program, 2001-2002. Matern Child Health J (2008) 1.00
Tobacco use during pregnancy among Alaska Natives in western Alaska. Alaska Med (2005) 1.00
Anesthesiologists, general surgeons, and tobacco interventions in the perioperative period. Anesth Analg (2004) 1.00
Personality characteristics of health care satisfaction survey non-respondents. Int J Health Care Qual Assur (2009) 0.99
MUC6 mucin expression inhibits tumor cell invasion. Exp Cell Res (2011) 0.99
Surgery versus conservative therapy in carpal tunnel syndrome in people aged 70 years and older. Plast Reconstr Surg (2006) 0.99
The role of the SEA (sea urchin sperm protein, enterokinase and agrin) module in cleavage of membrane-tethered mucins. FEBS J (2005) 0.98
Clinician-delivered intervention to facilitate tobacco quitline use by surgical patients. Anesthesiology (2011) 0.98
Optic neuropathy of Graves disease: results of transantral orbital decompression and long-term follow-up in 215 patients. Am J Ophthalmol (2003) 0.97
Molecular mechanisms controlling CFTR gene expression in the airway. J Cell Mol Med (2012) 0.97
Trends and risk factors for prostate biopsy complications in the pre-PSA and PSA eras, 1980 to 1997. Urology (2002) 0.96
A T3 allele in the CFTR gene exacerbates exon 9 skipping in vas deferens and epididymal cell lines and is associated with Congenital Bilateral Absence of Vas Deferens (CBAVD). Hum Mutat (2005) 0.95
N-Glycosylation of the MUC1 mucin in epithelial cells and secretions. Glycobiology (2006) 0.95
Body image treatment for weight concerned smokers: a pilot study. Addict Behav (2004) 0.95
Novel regulatory mechanisms for the CFTR gene. Biochem Soc Trans (2009) 0.94
Optimism-pessimism assessed in the 1960s and self-reported health status 30 years later. Mayo Clin Proc (2002) 0.94
The characterization of the first anti-mouse Muc6 antibody shows an increased expression of the mucin in pancreatic tissue of Cftr-knockout mice. Histochem Cell Biol (2010) 0.93
Nucleosome mapping across the CFTR locus identifies novel regulatory factors. Nucleic Acids Res (2013) 0.92
Personality correlates related to tobacco abstinence following treatment. Int J Psychiatry Med (2005) 0.92
Mucin variable number tandem repeat polymorphisms and severity of cystic fibrosis lung disease: significant association with MUC5AC. PLoS One (2011) 0.92
Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia. Prostate (2006) 0.91
The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways. PLoS One (2012) 0.91
Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival. J Urol (2002) 0.91
Deletion of CFTR translation start site reveals functional isoforms of the protein in CF patients. Cell Physiol Biochem (2009) 0.90
A survey of characteristics of smokeless tobacco users in a treatment program. Am J Health Behav (2004) 0.90
Methods for RNA extraction, cDNA preparation and analysis of CFTR transcripts. J Cyst Fibros (2004) 0.89
The contribution of tandem repeat number to the O-glycosylation of mucins. Glycobiology (2002) 0.89
Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia. Am J Epidemiol (2004) 0.89
Atypical 5' splice sites cause CFTR exon 9 to be vulnerable to skipping. Am J Hum Genet (2002) 0.88
Transcriptional regulation of CFTR gene expression. Front Biosci (Elite Ed) (2012) 0.88
Development and preliminary evaluation of a measure of support provided to a smoker among young adults. Addict Behav (2005) 0.88
A genome-wide analysis of open chromatin in human tracheal epithelial cells reveals novel candidate regulatory elements for lung function. Thorax (2011) 0.88
Focus groups of Alaska Native adolescent tobacco users: preferences for tobacco cessation interventions and barriers to participation. Health Educ Behav (2007) 0.88
Development of a telephone-based intervention for support persons to help smokers quit. Psychol Health Med (2008) 0.88
Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation. Am J Kidney Dis (2005) 0.87
Evaluation of gene targeting by homologous recombination in ovine somatic cells. Mol Reprod Dev (2003) 0.87
Expressive writing intervention for young adult cigarette smokers. J Clin Psychol (2005) 0.87
Frequency and type of use of a home-based, Internet intervention for adolescent smoking cessation. J Adolesc Health (2007) 0.87
DNA polymorphisms in potential regulatory elements of the CFTR gene alter transcription factor binding. Hum Genet (2002) 0.86
Relationship of tobacco use to depressive disorders and suicidality among patients treated for alcohol dependence. Am J Addict (2003) 0.86
Quantitative methods for the analysis of CFTR transcripts/splicing variants. J Cyst Fibros (2004) 0.86
Immune mediators regulate CFTR expression through a bifunctional airway-selective enhancer. Mol Cell Biol (2013) 0.85
Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH. Prostate (2005) 0.85
Comparability of proptosis measurements by different techniques. Am J Ophthalmol (2002) 0.85
A genome-wide analysis of open chromatin in human epididymis epithelial cells reveals candidate regulatory elements for genes coordinating epididymal function. Biol Reprod (2013) 0.85
A prospective, case-control study of tobacco dependence in thromboangiitis obliterans (Buerger's Disease). Angiology (2006) 0.85
Effect of nicotine replacement therapy on stress and smoking behavior in surgical patients. Anesthesiology (2005) 0.85
Nucleosome occupancy reveals regulatory elements of the CFTR promoter. Nucleic Acids Res (2011) 0.85
Collagen XV inhibits epithelial to mesenchymal transition in pancreatic adenocarcinoma cells. PLoS One (2013) 0.85
Hispanic Infants with cystic fibrosis show low CFTR mutation detection rates in the Illinois newborn screening program. J Genet Couns (2012) 0.84
Validation of an improved pediatric weight estimation strategy. J Pediatr Pharmacol Ther (2013) 0.84
Interaction of intestinal and pancreatic transcription factors in the regulation of CFTR gene expression. Biochim Biophys Acta (2009) 0.84
Bupropion for pharmacologic relapse prevention to smoking: predictors of outcome. Addict Behav (2002) 0.84